Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.01M Buy
+175,000
New +$8.28M ﹤0.01% 1710
2023
Q3
Sell
-311,208
Closed -$14.8M 5770
2023
Q2
$14.8M Buy
+311,208
New +$15M 0.01% 956
2020
Q4
Sell
-94,306
Closed -$5.23M 7576
2020
Q3
$5.23M Hold
94,306
﹤0.01% 1852
2020
Q2
$4.28M Buy
94,306
+61,393
+187% +$2.75M ﹤0.01% 2007
2020
Q1
$1.45M Hold
32,913
﹤0.01% 2805
2019
Q4
$1.18M Buy
+32,913
New +$1.22M ﹤0.01% 3591

Other funds holding QGEN

Citigroup's QGEN Position: Q1 2026 in Review

Citigroup reduced its Qiagen (QGEN) stake by 1.8% in Q1 2026, selling an estimated $1.22M and leaving 1,385,111 shares worth $55.5M. The position accounts for 0.02% of the portfolio, ranked #601.

Citigroup first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $437M in Q2 2020. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Citigroup held 1,385,111 shares of Qiagen worth $55.5M as of Q1 2026.
  • Citigroup sold 25,825 Qiagen shares in Q1 2026, an estimated $1.22M.
  • Qiagen made up 0.02% of Citigroup's portfolio in Q1 2026, its #601 holding.
  • Citigroup first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • Citigroup's Qiagen position peaked at $437M in Q2 2020.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.